Month: February 2010

Patient involvement in the approval of new drugs

Patient can contribute to the drug development and approval process by enrolling themselves in clinical trials. Participating in clinical trials not only contributes to improvements in cancer research and treatment but also allows enrolled patients access to closely monitored care and regular reviews on the status of their disease. The FDA has launched two programs …

Patient involvement in the approval of new drugs Read More »

Some FDA initiatives for improving the process of drug development and approval in the United States.

1) Accelerated approval The accelerated approval program run by FDA allows sponsors to request approval on the basis of alternate findings. Also called surrogate endpoints, these are indirect assessments of disease status, for example, a change in lab results or improvements in symptoms related to the disease. These endpoints can also be used to assess …

Some FDA initiatives for improving the process of drug development and approval in the United States. Read More »

Cancer Cell Metabolism Could Be Key To New Cancer Therapies

Way back in the 1920s, a German scientist by the name of Otto Warburg reported to the world that cancer cells metabolize sugars in different ways than normal healthy cells. While such a discovery may not seem particularly momentous, this near century-old discovery is continuing to prove its importance by opening the door to a …

Cancer Cell Metabolism Could Be Key To New Cancer Therapies Read More »

FDA fast track program

With its fast track drug development programs, the FDA seeks to facilitate the development of new drugs and speed up their approval process. This is especially true in case of drugs that can provide for unmet medical needs pertaining to debilitating or life-threatening diseases such as cancer. An unmet medical need is said to exist …

FDA fast track program Read More »